These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20467154)

  • 1. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kita T
    Circ J; 2010 Jul; 74(7):1399-404. PubMed ID: 20467154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble lectin-like oxidized LDL receptor-1 and high-sensitivity troponin T as diagnostic biomarkers for acute coronary syndrome. Improved values with combination usage in emergency rooms.
    Kobayashi N; Hata N; Kume N; Shinada T; Tomita K; Shirakabe A; Kitamura M; Nozaki A; Inami T; Seino Y; Mizuno K
    Circ J; 2011; 75(12):2862-71. PubMed ID: 21937834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.
    Kobayashi N; Takano M; Hata N; Kume N; Yamamoto M; Yokoyama S; Shinada T; Tomita K; Shirakabe A; Otsuka T; Seino Y; Mizuno K
    Int J Cardiol; 2013 Oct; 168(4):3217-23. PubMed ID: 23632121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kominami G; Kita T
    J Cardiol; 2010 Sep; 56(2):159-65. PubMed ID: 20605699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis.
    Hayashida K; Kume N; Murase T; Minami M; Nakagawa D; Inada T; Tanaka M; Ueda A; Kominami G; Kambara H; Kimura T; Kita T
    Circulation; 2005 Aug; 112(6):812-8. PubMed ID: 16061745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein.
    Mitsuoka H; Toyohara M; Kume N; Hayashida K; Jinnai T; Tanaka M; Kita T
    J Atheroscler Thromb; 2009 Oct; 16(5):586-93. PubMed ID: 19729872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay.
    Nakamura M; Ohta H; Kume N; Hayashida K; Tanaka M; Mitsuoka H; Kaneshige T; Misaki S; Imagawa K; Shimosako K; Ogawa N; Kita T; Kominami G
    J Pharm Biomed Anal; 2010 Jan; 51(1):158-63. PubMed ID: 19632802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of sLOX-1 Level in Acute Coronary Syndromes Based on Thrombolysis in Myocardial Infarction Risk Score and Clinical Outcome.
    Mashayekhi S; Ziaee M; Garjani A; Sarbakhsh P; Ghaffari S
    J Emerg Med; 2018 Sep; 55(3):390-398. PubMed ID: 30049431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes.
    Çoner A; Aydınalp A; Müderrisoğlu H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):96-103. PubMed ID: 30961517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
    Kraler S; Wenzl FA; Georgiopoulos G; Obeid S; Liberale L; von Eckardstein A; Muller O; Mach F; Räber L; Losdat S; Schmiady MO; Stellos K; Stamatelopoulos K; Camici GG; Srdic A; Paneni F; Akhmedov A; Lüscher TF
    Eur Heart J; 2022 May; 43(19):1849-1860. PubMed ID: 35567560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of plaque ruptures using a novel discriminative model comprising biomarkers in patients with acute coronary syndrome.
    Kook H; Jang DH; Kim JH; Cho JY; Joo HJ; Cho SA; Park JH; Hong SJ; Yu CW; Lim DS
    Sci Rep; 2020 Nov; 10(1):20228. PubMed ID: 33214686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: A multicentre pilot study.
    Zhao ZW; Xu YW; Li SM; Guo JJ; Yi T; Chen LL
    Biochem Med (Zagreb); 2019 Feb; 29(1):010705. PubMed ID: 30799974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome.
    Kumar S; Ali W; Mishra S; Pradhan A; Sethi R; Kushwaha R; Singh US; Perrone MA
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) and sLOX-1/oxidized LDL ratio as novel biomarkers of acute coronary syndrome.
    Hussein RA; Abdul-Rasheed OF; Basheer M
    Acta Biochim Pol; 2022 Apr; 69(2):309-314. PubMed ID: 35389578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases.
    Pirillo A; Catapano AL
    Dis Markers; 2013; 35(5):413-8. PubMed ID: 24198442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome.
    Stankova T; Delcheva G; Maneva A; Vladeva S
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443320
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of soluble lectin-like oxidized LDL receptor-1 levels in systemic and coronary circulation in acute coronary syndrome.
    Misaka T; Suzuki S; Sakamoto N; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Saitoh S; Sawamura T; Ishibashi T; Takeishi Y
    Biomed Res Int; 2014; 2014():649185. PubMed ID: 24895597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low-density lipoprotein and C-reactive protein have combined utility for better predicting prognosis after acute coronary syndrome.
    Zhang YC; Tang Y; Chen Y; Huang XH; Zhang M; Chen J; Sun YG; Li YG
    Cell Biochem Biophys; 2014 Mar; 68(2):379-85. PubMed ID: 23943054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention.
    Zhao ZW; Xu YW; Li SM; Guo JJ; Sun JM; Hong JC; Chen LL
    Dis Markers; 2019; 2019():4925767. PubMed ID: 31772687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with erectile dysfunction in patients without known coronary artery disease.
    Kobat MA; Fırdolas F; Balin M; Çelik A; Bentli R; Baydas A
    J Sex Med; 2013 Nov; 10(11):2782-9. PubMed ID: 23088332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.